SynapCell

RESOURCES

SynapCell-In-vivo-efficacy-Testing-on-CNS-disorders
DOWNLOAD BROCHURE
FAQ-synapcell-In-vivo-efficacy-Testing-on-CNS-disorders
DOWNLOAD FAQ
Youtube-Channel-SynapCell
checkout videos

Epilepsy Therapies & Diagnostics Development (ETDD)

CNS Therapeutics XChange 2023 East Coast and Essential Tremor Congress

SynapCell Sponsor of ASENT 2023

Society for Neuroscience 2022 – San Diego

CNS Therapeutics Xchange 2022 – Europe Zürich

BioJapan 2022

CNS Therapeutics Xchange 2022 – US West Coast

Synapcell showcased into GEN magazine

NEUROSCIENCE EVENTS IN PARIS, JULY 2022

SynapCell’s experts hit the West Coast road ! [June 2022]

EILAT XVI CONFERENCE ON NEW ANTIEPILEPTIC DRUGS & DEVICES

ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease

ASENT 2022

Synapcell and Reservoir Neuroscience announce collaboration for development of treatment for chronic epilepsy

AES 2021: Partnership with OVID Threapeutics in Epilepsy

CNS Therapeutics Xchange 2021

Society for Neuroscience 2021

IPEG 2021. A Virtual Event

BioJapan 2021 & more!

Let's talk about your next project

Contact the team
Logo-Synapcell
SynapCell
Bâtiment SYNERGY
ZAC ISIPARC
38330 Saint Ismier – France
 
+33 (0) 458 171 583
Linkedin Twitter Youtube

About

biomarkers

FOCUS

  • EPILEPSY
  • PARKINSON'S DISEASE​

OPEN INNOVATION

CAPABILITIES

SYNAPCELL 2022 © – All Rights Reserved